Identifying breast cancer types using a blood test
Molecular Sub-typing Breast Cancer Patients using a Liquid Biopsy
['FUNDING_R21'] · UNIVERSITY OF KANSAS LAWRENCE · NIH-10919194
This study is looking at how blood tests can help identify different types of breast cancer by examining tiny particles in your blood, making it easier and less invasive to understand your cancer and find the best treatment for you.
Quick facts
| Phase | ['FUNDING_R21'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF KANSAS LAWRENCE (nih funded) |
| Locations | 1 site (LAWRENCE, UNITED STATES) |
| Trial ID | NIH-10919194 on ClinicalTrials.gov |
What this research studies
This research investigates the use of liquid biopsies, which are blood samples, to identify different molecular subtypes of breast cancer. By analyzing extracellular vesicles in these samples, the study aims to provide a less invasive method for determining the specific characteristics of a patient's cancer. This approach could help tailor treatment plans more effectively by understanding the unique molecular profile of each tumor. The research utilizes advanced techniques to analyze the genetic material present in the blood, potentially offering insights similar to those obtained from traditional tissue biopsies.
Who could benefit from this research
Good fit: Ideal candidates for this research are women diagnosed with early-stage breast cancer who are undergoing treatment.
Not a fit: Patients with advanced-stage breast cancer or those who have already received extensive treatment may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more personalized and effective treatment options for breast cancer patients.
How similar studies have performed: Other research has shown promising results using liquid biopsies for cancer detection, indicating that this approach may be effective.
Where this research is happening
LAWRENCE, UNITED STATES
- UNIVERSITY OF KANSAS LAWRENCE — LAWRENCE, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: SOPER, STEVEN ALLAN — UNIVERSITY OF KANSAS LAWRENCE
- Study coordinator: SOPER, STEVEN ALLAN
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: American Cancer Society